Latest / Mesa News Today | 2 Min News | The Daily News Now!
Moderna’s Flu Vaccine Gets FDA Approval | Mesa News
Moderna’s new mRNA flu vaccine, mFlusiva, just got full FDA approval for ages 50-64 and accelerated approval for those 65+, marking a major leap in flu prevention using the same tech that powered COVID vaccines. After a rocky start—including an initial FDA pause and political hurdles with Health Secretary Robert F. Kennedy Jr.—the vaccine proved 27% more effective than standard shots in its target group, with only mild side effects. With doses rolling out soon, this faster-to-produce mRNA option could save lives—especially among older adults—and adapt quicker if flu strains mutate. Listen in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.